Dr. David M. Faleck, MD

Dr. Faleck practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Faleck's NPI, 1255607669, was assigned on March 29, 2012. Dr. Faleck graduated from Albert Einstein College of Medicine in 2012. Dr. Faleck holds New York license 279006.

Dr. Faleck's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Dr. Faleck's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Sloan Kettering Cancer Center. Dmand AI also links Dr. Faleck to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Faleck practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Faleck's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Faleck is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Faleck's licenses on file in 4 states: New York, Florida, New Jersey and Connecticut.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), colonoscopy, gastroenteritis, gastrointestinal bleeding, hemorrhoids, intestinal or bowel obstruction and irritable bowel syndrome (IBS) among the conditions Dr. Faleck treats.

CMS data shows 576 Medicare services from Dr. Faleck across 12 procedure codes in 2024, for 307 Medicare patients. Medicare paid $63,495 for them.

CMS counts 307 Medicare patients who saw Dr. Faleck in 2024. The largest group is 65 to 74, with 156 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Faleck's median patient age at 71, with 46% women.

In 2024, Dr. Faleck wrote 560 Medicare Part D claims for 147 patients. 74% of them were for generic drugs. CMS names the drug for 420 of them, across 14 drugs with 11 or more claims each, at $650,981 in total drug cost. In 2023, CMS named 374 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Faleck for performance year 2024, reported as part of a group. Dr. Faleck accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Faleck as offering telehealth. CMS counts 91 procedures of colonoscopy by Dr. Faleck, more than 78% of the clinicians it reports for that procedure.

Dmand AI links 43 papers to Dr. Faleck, published from 2009 to 2024. 2023 was the busiest year, with 6. The most frequent topics are Immune Checkpoint Inhibitors, Colitis and Antibodies, Monoclonal, Humanized. Dr. Faleck has published most often in Am J Gastroenterol. Dr. Faleck's most frequent co-authors are Shannon Shung-Ling Chang, MD, Dana Jeremy Lukin, MD, PhD and Sunanda V. Kane, MD.

Dmand AI links Dr. Faleck to 1 clinical trial. 1 is still active or recruiting.

CMS Open Payments shows 29 general payments to Dr. Faleck from 9 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 95% of the total. Janssen Research & Development, LLC paid the most, $16,050.

Dmand AI lists 1 award for Dr. Faleck, most recently Member in 2012.

Dr. Faleck graduated from Albert Einstein College of Medicine in 2012.

Dr. Faleck is in network with 13 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.